Search the web
Welcome, Guest
[Sign Out, My Account]

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
ENZN > SEC Filings for ENZN > Form 8-K on 15-Oct-2013All Recent SEC Filings




Other Events

Item 8.01 Other Events.

On October 14, 2013, the Board of Directors (the "Board") of Enzon Pharmaceuticals, Inc. (the "Company") appointed Jonathan Christodoro as Chairman of the Board's Finance and Audit Committee (the "Finance and Audit Committee") and Odysseas Kostas and Jennifer I. McNealey as members of the Finance and Audit Committee. Following such appointments, the Finance and Audit Committee currently consists of Mr. Christodoro (Chairman), Dr. Kostas, Ms. McNealey and Richard A. Young. The Board has determined that each current member of the Finance and Audit Committee is independent as defined by NASDAQ listing standards and that Mr. Christodoro satisfies the definition of "audit committee financial expert" within the meaning of Item 407(d)(5) of Regulation S-K.

Mr. Christodoro, Dr. Kostas and Ms. McNealey will stand for election at the Company's 2013 annual meeting of stockholders to be held on Wednesday, November 20, 2013 (the "2013 Annual Meeting"). Dr. Young will not stand for re-election at the 2013 Annual Meeting.

  Add ENZN to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for ENZN - All Recent SEC Filings
Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.